PaxeraHealth announced that the University of Pennsylvania has selected its zero-coding authoring platform to assist in their development of new imaging AI algorithms. ARK’s offering of “Algorithms as a service” aim to help healthcare systems and academic and research centers to DIY (Do-It-Yourself) their own AI algorithms for all possible modalities, body parts, and anomalies.

May 27, 2022 — PaxeraHealth announced that the University of Pennsylvania has selected its zero-coding authoring platform to assist in their development of new imaging AI algorithms. ARK’s offering of “Algorithms as a service” aim to help healthcare systems and academic and research centers to DIY (Do-It-Yourself) their own AI algorithms for all possible modalities, body parts, and anomalies. UPenn’s ultrasound research lab – Department of Radiology will use the platform to elevate the research and development of their associated imaging laboratories and expedite production of their focused algorithms.

“PaxeraHealth is pleased to offer our zero-coding authoring tools to the help ultrasound research team at UPenn complete the development of their algorithms for the sake of future patients everywhere,” said Dr. Mohamed Shoura, CEO of PaxeraHealth. “We understand the frustrations that come with developing new imaging algorithms and aim to eliminate these with the ARK platform.”

“Aligning UPenn’s research and primary development with Paxera’s high-end tools will expedite our timeline significantly and allow these algorithms to go to market much sooner than estimated”, added Dr. Sandy Sehgal, Professor and Director of ultrasound research at UPenn.

“PaxeraHealth’s ARK platform will be a key element in completing the development of these important algorithms,” added Dr. Laith Sultan, physician scientist at UPenn.

The collaboration between UPenn and Paxera will focus on the development of imaging algorithms to detect liver cancer as well as COVID detection via lung ultrasound. ARK’s high-end modeling, annotation, and data curation tools will reduce development timeline and expedite clinical validation, allowing UPenn to complete and commercialize their new algorithms and make them accessible to PaxeraHealth’s worldwide user base.

For more information: www.paxerahealth.com

 


Related Content

News | Artificial Intelligence

December 6, 2023 — The American Medical Association (AMA) released new principles for augmented intelligence (AI) ...

Time December 06, 2023
arrow
News | Enterprise Imaging

December 6, 2023 — NVIDIA launched a cloud service for medical imaging AI to further streamline and accelerate the ...

Time December 06, 2023
arrow
News | Ultrasound Imaging

December 6, 2023 — Clarius Mobile Health has been awarded a Technology Breakthrough Designation in the Ultrasound ...

Time December 06, 2023
arrow
News | Digital Pathology

December 6, 2023 — One of the largest independent pathology service providers in the United States, CellNetix Pathology ...

Time December 06, 2023
arrow
News | Artificial Intelligence

December 5, 2023 — Radiology is under severe economic pressure as reimbursement rates fall for many common scans. At the ...

Time December 05, 2023
arrow
Feature | Radiology Business | By Melinda Taschetta-Millane

During the month of November, many industry professionals were busy preparing for the Radiological Society of North ...

Time December 05, 2023
arrow
News | Radiology Business

December 4, 2023 — Ajay Gupta, MD, MS, has been named chair of the Department of Radiology at Columbia University ...

Time December 04, 2023
arrow
News | RSNA

December 1, 2023 — Royal Philips, a global leader in health technology, put patients and healthcare providers center ...

Time December 01, 2023
arrow
News | RSNA

December 1, 2023 —Nuance Communications, Inc., a Microsoft Company, during the 2023 Radiological Society of North ...

Time December 01, 2023
arrow
News | RSNA

December 1, 2023 — In today's healthcare environment, the industry faces various pressing challenges. The magnetic ...

Time December 01, 2023
arrow
Subscribe Now